Breast Cancer Update Think Tank - 2 | 2006

You are here: Home: BCU 2 | 2006 Think Tank: Section 2: Select publications

SELECT PUBLICATIONS

Hyder SM. Sex-steroid regulation of vascular endothelial growth factor in breast cancer. Endocr Relat Cancer 2006;13(3):667-87. Abstract

Traina TA et al. Letrozole (L) with bevacizumab (B) is feasible in patients (pts) with hormone receptor-positive metastatic breast cancer (MBC). Proc ASCO 2006;Abstract 3050.

Home · Search

Editor’s Note:
All-Star Journal Club

Topics
Section 1:
Bevacizumab Plus Chemotherapy as First-Line
Therapy of Metastatic Breast Cancer
- Select publications

Section 2:
Rationale for Combining Bevacizumab and
Hormone Therapy
- Select publications

Section 3:
Utility of the Oncotype DX™ Assay in Predicting
Benefit of Adjuvant Chemotherapy
- Select publications

Section 4:
Use of the Oncotype DX Assay in Clinical Practice
- Select publications

Section 5:
Optimizing Adjuvant Chemotherapy
- Select publications

Section 6:
Cardiac Toxicity Associated with Anthracycline-
Based Chemotherapy (Nonanthracycline Alternatives)
- Select publications

Section 7:
Trastuzumab as Adjuvant Therapy for HER2-Positive Breast Cancer
- Select publications

Section 8:
Treatment of HER2-Positive Metastatic Disease
- Select publications

CME Information

Faculty Disclosures

Editor's Office

Terms and Conditions of Use and General Disclaimer
Copyright © 2006 Research To Practice. All Rights Reserved